H

Hester Biosciences

(NSE: HESTERBIO)

HESTERBIO

2011.6

0.00 (0.00%)

Hester Biosciences Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Hester Biosciences Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Hester Biosciences Price Summary

Today High

2035

Today Low

1971.7

52 Week High

2035

52 Week Low

1971.7

Hester Biosciences Fundamentals

Market Cap

2222.1 Cr

CASA

0.0

No. Of Shares

85.07 L

P/E

40.9

P/B

6.9

Face Value

10.0

Dividend Yeild

0.5

Book Value

279.3

Net Interest Income

2.6

Cost to Income

NA

Promoter Holdings

53.7

EPS

46.9

CAR

NA

ROE

18.1

ROCE

23.3

Profit Growth

NA

Hester Biosciences Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Hester Biosciences

2011.6

2222.1 Cr

6.9

40.9

46.9

18.1

23.3

2.6

Amrutanjan Health

714.8

2214.5 Cr

7.7

27.1

20.9

32.7

44.0

938.8

Morepen Labs

23.85

2264.9 Cr

3.6

15.3

2.1

26.6

24.5

213.4

Marksans Pharma

46.6

2138.7 Cr

3.4

20.8

2.4

17.8

23.5

1.1 Cr

Gufic Biosciences

217.25

2433.8 Cr

6.4

25.1

4.6

29.2

30.0

145.1

Unichem Laboratories

388.55

1874.6 Cr

0.8

40.3

7.7

2.0

2.5

2.3K

FAQ’s on Hester Biosciences

About Hester Biosciences

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company

Trade Hester Biosciences today

Create a free portfolio in Trinkerr and earn and grow along with peers